TD ASSET MANAGEMENT INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,529,155
+29.6%
336,078
+100.6%
0.00%
+100.0%
Q2 2023$1,179,594
+65.5%
167,556
+43.6%
0.00%0.0%
Q1 2023$712,768
-2.7%
116,656
+1.7%
0.00%0.0%
Q4 2022$732,652
-47.9%
114,656
-22.3%
0.00%
-50.0%
Q3 2022$1,406,000
-5.8%
147,556
+9.1%
0.00%0.0%
Q2 2022$1,493,000
-44.3%
135,256
-16.0%
0.00%0.0%
Q1 2022$2,680,000
+1.2%
160,968
+16.0%
0.00%0.0%
Q4 2021$2,648,000
-18.3%
138,724
+5.5%
0.00%
-33.3%
Q3 2021$3,241,000
+10.7%
131,4440.0%0.00%0.0%
Q2 2021$2,927,000
-41.9%
131,444
-17.5%
0.00%
-50.0%
Q1 2021$5,042,000
-44.6%
159,264
-18.8%
0.01%
-45.5%
Q4 2020$9,101,000
+60.4%
196,142
+13.8%
0.01%
+37.5%
Q3 2020$5,673,000
+19.9%
172,3150.0%0.01%
+14.3%
Q2 2020$4,730,000
+0.8%
172,315
+9.9%
0.01%
-12.5%
Q1 2020$4,694,000
+1.2%
156,808
-6.4%
0.01%
+14.3%
Q4 2019$4,639,000
+48.4%
167,608
-2.4%
0.01%
+40.0%
Q3 2019$3,127,000
-22.8%
171,808
+3.9%
0.01%
-16.7%
Q2 2019$4,053,000
+289.3%
165,308
+51.0%
0.01%
+200.0%
Q1 2019$1,041,000
+6.9%
109,508
-0.5%
0.00%0.0%
Q4 2018$974,000
-15.5%
110,008
+7.4%
0.00%0.0%
Q3 2018$1,152,000
-8.9%
102,400
+3.6%
0.00%0.0%
Q2 2018$1,265,000
-2.0%
98,800
+29.3%
0.00%0.0%
Q1 2018$1,291,00076,4000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders